![]() |
|
|
Vol. 296, Issue 1, 7-14, January 2001
Research Service, Zablocki Veterans Affairs Medical Center,
Milwaukee, Wisconsin (J.J.R., J.M.F.); and Department of
Pharmacology, Medical College of Wisconsin, Milwaukee, Wisconsin
(J.J.R., W.B.C., J.M.F.)
An antianalgesic action of intracerebroventricularly administered
nociceptin was elicited against intrathecal morphine-induced antinociception in the tail-flick test in mice and investigated as a
descending neuronal system for the spinal mediator involved. The
nociceptin-induced antianalgesia originating in the brain was inhibited
by intrathecally administered indomethacin and suggested the mediation
of spinal prostaglandin. The antianalgesic action of
intracerebroventricular nociceptin was closely matched by intrathecal prostaglandin (PG) E2. Both shifted the dose-response curve
of morphine to the right and these actions were eliminated by
intrathecal PGD2. Desensitization of the antianalgesic
action of PGE2 by intrathecal PGE2 pretreatment
also produced cross-desensitization to the antianalgesic action of
intracerebroventricular nociceptin. Neither intracerebroventricular nociceptin nor intrathecal PGE2 produced antianalgesia
against the
-receptor agonists given intrathecally. Thus, the
antianalgesic action of nociceptin originating in the brain is coupled
to a descending neuronal pathway mediated by spinal PGE2.
This article has been cited by other articles:
![]() |
J. J. Rady and J. M. Fujimoto Confluence of Antianalgesic Action of Diverse Agents through Brain Interleukin1beta in Mice J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 659 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mogil and G. W. Pasternak The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415. [Abstract] [Full Text] [PDF] |
||||